| Evithrom |
125247 |
003 |
351(a) |
Thrombin, Topical (Human) |
Solution |
Topical |
5ML IU/ML |
Single-Dose Vial |
2007/08/27
|
Omrix Biopharmaceuticals Ltd |
Disc |
Licensed |
|
N/A |
| Privigen |
125201 |
001 |
351(a) |
Immune Globulin Intravenous (Human), 10% Liquid |
Injection |
Intravenous |
20G |
Single-Dose Vial |
2007/07/26
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Privigen |
125201 |
002 |
351(a) |
Immune Globulin Intravenous (Human), 10% Liquid |
Injection |
Intravenous |
10G |
Single-Dose Vial |
2007/07/26
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Privigen |
125201 |
003 |
351(a) |
Immune Globulin Intravenous (Human), 10% Liquid |
Injection |
Intravenous |
5G |
Single-Dose Vial |
2007/07/26
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Advate |
125063 |
006 |
351(a) |
Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method |
For Injection |
Intravenous |
3000IU |
Single-Dose Vial |
2007/07/03
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Helixate Fs, Kogenate, Kogenate Fs |
103332 |
004 |
351(a) |
Antihemophilic Factor (Recombinant) |
For Injection |
Intravenous |
2000IU |
Single-Dose Vial |
2007/06/07
|
Bayer HealthCare LLC |
Disc |
Licensed |
|
N/A |
| Lantus |
021081 |
002 |
351(a) |
insulin glargine |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
2007/04/25
|
Sanofi-Aventis U.S. LLC |
Rx |
Licensed |
N/A |
N/A |
|
125244 |
001 |
351(a) |
Influenza Virus Vaccine, H5N1 |
Injection |
Intramuscular |
90 MG/.5ML |
Vial |
2007/04/17
|
Sanofi Pasteur Inc. |
Disc |
Licensed |
|
N/A |
| Ceprotin |
125234 |
001 |
351(a) |
Protein C Concentrate (Human) |
For Injection |
Intravenous |
500IU |
Single-Dose Vial |
2007/03/30
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Ceprotin |
125234 |
002 |
351(a) |
Protein C Concentrate (Human) |
For Injection |
Intravenous |
1000IU |
Single-Dose Vial |
2007/03/30
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Erbitux |
125084 |
002 |
351(a) |
cetuximab |
Injection |
Intravenous |
200MG/100ML (2MG/ML) |
Single-Dose Vial |
2007/03/28
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Octagam |
125062 |
005 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5% 25G |
Single-Use Bottle |
2007/03/26
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
| Benefix |
103677 |
004 |
351(a) |
Coagulation Factor IX (Recombinant) |
For Injection |
Intravenous |
2000IU/ML |
Single-Dose Vial |
2007/03/21
|
Wyeth Pharmaceuticals LLC |
Rx |
Licensed |
|
N/A |
| Soliris |
125166 |
001 |
351(a) |
eculizumab |
Injection |
Intravenous |
300MG/30ML (10MG/ML) |
Single-Dose Vial |
2007/03/16
|
Alexion Pharmaceuticals, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Enbrel |
103795 |
004 |
351(a) |
etanercept |
Injection |
Subcutaneous |
25MG/0.5ML |
Pre-Filled Syringe |
2007/02/01
|
Immunex Corporation |
Rx |
Licensed |
N/A |
N/A |
| Saizen |
019764 |
005 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
4MG |
Single-Dose Vial |
2007/01/16
|
EMD Serono, Inc. |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Flebogamma 5%, Flebogamma 5% Dif |
125077 |
005 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
20G/400ML |
Single-Dose Vial |
2006/12/21
|
Instituto Grifols, S.A. |
Rx |
Licensed |
|
N/A |
|
125154 |
001 |
351(a) |
Albumin (Human) |
Injection |
Intravenous |
12.5G/250ML |
Single-Use Bottle |
2006/10/17
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
|
125154 |
002 |
351(a) |
Albumin (Human) |
Injection |
Intravenous |
5G/100ML |
Single-Use Bottle |
2006/10/17
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |
|
125154 |
004 |
351(a) |
Albumin (Human) |
Injection |
Intravenous |
25G/100ML |
Single-Use Bottle |
2006/10/17
|
Octapharma Pharmazeutika Produktionsges.m.b.H. |
Rx |
Licensed |
|
N/A |